{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:50Z","timestamp":1759336250558,"version":"3.37.3"},"reference-count":60,"publisher":"The Journal of Rheumatology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2023,7,21]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To develop a list of tests or treatments frequently used in pediatric rheumatology practice that may be unnecessary based on existing evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A Choosing Wisely (CW) working group composed of 16 pediatric rheumatologists, 1 allied health professional, 1 parent, and 1 patient used the Delphi method to generate, rank, and refine a list of tests and treatments that may be unnecessary or harmful. The items with the highest content agreement and perceived impact were presented in a survey to all Canadian Rheumatology Association (CRA) physicians who practice pediatric rheumatology. Respondents were asked to rate their agreement and impact, and to rank the items. Five items with the highest composite scores and 2 additional items selected by the CW working group were put forward for literature review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The initial Delphi procedure generated 80 items. After 3 rounds, the list was narrowed to 13 items. The survey was completed by 41\/81 (51%) CRA pediatric members across Canada. Respondent characteristics were similar to those of the CRA pediatric membership for self-reported gender, geographical location, and career stage. The highest composite score items were antinuclear antibody testing, drug toxicity monitoring, HLA-B27 testing, rheumatoid factor\/anticyclic citrullinated peptide testing, and Lyme serology testing. Two additional items (numerous or repeated intraarticular corticosteroid injections, and autoinflammatory diseases genetic testing) were also selected. Literature review was performed for these 7 highest priority items.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We have identified areas for quality improvement in the evaluation and treatment of rheumatic diseases in Canadian children.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.2023-0043","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:21:03Z","timestamp":1690892463000},"page":"1610-1618","source":"Crossref","is-referenced-by-count":1,"title":["Choosing Wisely: The Canadian Rheumatology Association Pediatric Committee\u2019s List of Items Physicians and Patients Should Question"],"prefix":"10.3899","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-7690","authenticated-orcid":false,"given":"Lillian","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4163-4993","authenticated-orcid":false,"given":"Tara","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-7776","authenticated-orcid":false,"given":"Ga\u00eblle","family":"Ch\u00e9deville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1427-4945","authenticated-orcid":false,"given":"Piya","family":"Lahiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5300-2662","authenticated-orcid":false,"given":"Jennifer J.Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-9917","authenticated-orcid":false,"given":"Liane D.","family":"Heale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-2806","authenticated-orcid":false,"given":"Andrea L.","family":"Human","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-1960","authenticated-orcid":false,"given":"Tara R.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4229-6159","authenticated-orcid":false,"given":"Sue E.","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-2562","authenticated-orcid":false,"given":"Elizabeth","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9319-7134","authenticated-orcid":false,"given":"Mehul P.","family":"Jariwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6872-1758","authenticated-orcid":false,"given":"Kate M.","family":"Neufeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-6245","authenticated-orcid":false,"given":"Gordon S.","family":"Soon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-0789","authenticated-orcid":false,"given":"Lynn R.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-7213","authenticated-orcid":false,"given":"Nadia J.C.","family":"Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"2024101604050994000_50.12.1610.1","unstructured":"Canadian Institute for Health Information . National health expenditure trends. [Internet. Accessed July 24, 2023.] Available from: https:\/\/www.cihi.ca\/sites\/default\/files\/document\/nhex-trends-2020-narrative-report-en.pdf"},{"key":"2024101604050994000_50.12.1610.2","unstructured":"Canadian Institute for Health Information . Unnecessary care in Canada [Internet. Accessed July 24, 2023.] Available from: https:\/\/www.cihi.ca\/sites\/default\/files\/document\/choosing-wisely-baseline-report-en-web.pdf"},{"key":"2024101604050994000_50.12.1610.3","unstructured":"Canadian Rheumatology Association . Nine tests and treatments to question in rheumatology. [Internet. Accessed July 24, 2023.] Available from: https:\/\/choosingwiselycanada.org\/recommendation\/rheumatology\/"},{"key":"2024101604050994000_50.12.1610.4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21930"},{"key":"2024101604050994000_50.12.1610.5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/acr.22238","article-title":"Choosing Wisely: the American College of Rheumatology\u2019s top 5 for pediatric rheumatology","volume":"66","author":"Rouster-Stevens","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2024101604050994000_50.12.1610.6","unstructured":"Linstone HA , Turoff M. The Delphi method: techniques and applications. Boston: Addison-Wesley Publishing Company; 1975."},{"key":"2024101604050994000_50.12.1610.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.1.174"},{"key":"2024101604050994000_50.12.1610.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.10561"},{"key":"2024101604050994000_50.12.1610.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141140"},{"key":"2024101604050994000_50.12.1610.10","unstructured":"Guidelines and Protocols Advisory Committee . Antinuclear antibody (ANA) testing protocol. [Internet. Accessed July 24, 2023.] Available from: https:\/\/www2.gov.bc.ca\/gov\/content\/health\/practitioner-professional-resources\/bc-guidelines\/ana-testing"},{"key":"2024101604050994000_50.12.1610.11","unstructured":"American Academy of Pediatrics\u2014Section on Rheumatology . Five things physicians and patients should question. [Internet. Accessed October 27, 2021.] Available from: https:\/\/publications.aap.org\/aapnews\/news\/12192\/New-Choosing-Wisely-list-pediatric-rheumatology"},{"key":"2024101604050994000_50.12.1610.12","doi-asserted-by":"publisher","DOI":"10.1309\/Y5VF-C3DM-L8XV-U053"},{"key":"2024101604050994000_50.12.1610.13","doi-asserted-by":"publisher","DOI":"10.1043\/0003-9985(2000)124&lt;0071:GFCUOT&gt;2.0.CO;2"},{"key":"2024101604050994000_50.12.1610.14","first-page":"153","article-title":"Prevalence of positive antinuclear antibodies in healthy children","volume":"23","author":"Wananukul","year":"2005","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2024101604050994000_50.12.1610.15","first-page":"1980","article-title":"Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians","volume":"25","author":"Suarez-Almazor","year":"1998","journal-title":"J Rheumatol"},{"key":"2024101604050994000_50.12.1610.16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jbspin.2020.05.007","article-title":"Appropriateness of laboratory tests in the diagnosis of inflammatory rheumatic diseases among patients newly referred to rheumatologists","volume":"87","author":"Ahrari","year":"2020","journal-title":"Joint Bone Spine"},{"key":"2024101604050994000_50.12.1610.17","unstructured":"Wong KO , Bond K , Homik J , Antinuclear antibody, rheumatoid factor, and cyclic-citrullinated peptide tests for evaluating musculoskeletal complaints in children. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012."},{"key":"2024101604050994000_50.12.1610.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.21602"},{"key":"2024101604050994000_50.12.1610.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216245"},{"key":"2024101604050994000_50.12.1610.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.12.002"},{"key":"2024101604050994000_50.12.1610.21","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/rheumatology\/kex389","article-title":"BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs","volume":"56","author":"Ledingham","year":"2017","journal-title":"Rheumatology"},{"key":"2024101604050994000_50.12.1610.22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00431-018-3286-8","article-title":"The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases","volume":"178","author":"Jacobse","year":"2019","journal-title":"Eur J Pediatr"},{"key":"2024101604050994000_50.12.1610.23","first-page":"2501","article-title":"Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis","volume":"31","author":"Ortiz-Alvarez","year":"2004","journal-title":"J Rheumatol"},{"key":"2024101604050994000_50.12.1610.24","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T"},{"key":"2024101604050994000_50.12.1610.25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/pds.4719","article-title":"Variation of the prevalence of pediatric polypharmacy: a scoping review","volume":"28","author":"Baker","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024101604050994000_50.12.1610.26","first-page":"2442","article-title":"Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy","volume":"29","author":"Lahdenne","year":"2002","journal-title":"J Rheumatol"},{"key":"2024101604050994000_50.12.1610.27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/acr.24839","article-title":"2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging","volume":"74","author":"Onel","year":"2022","journal-title":"Arthritis Care Res"},{"key":"2024101604050994000_50.12.1610.28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12969-020-00445-6","article-title":"Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists","volume":"18","author":"Nicek","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"2024101604050994000_50.12.1610.29","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133645"},{"key":"2024101604050994000_50.12.1610.30","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3029-4"},{"key":"2024101604050994000_50.12.1610.31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0000000000000313","article-title":"Update on enthesitis-related arthritis","volume":"28","author":"Weiss","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2024101604050994000_50.12.1610.32","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31820f8c99"},{"key":"2024101604050994000_50.12.1610.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182"},{"key":"2024101604050994000_50.12.1610.34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-14"},{"key":"2024101604050994000_50.12.1610.35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem348"},{"key":"2024101604050994000_50.12.1610.36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-017-1297-x","article-title":"Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches","volume":"19","author":"Gmuca","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2024101604050994000_50.12.1610.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.24539"},{"key":"2024101604050994000_50.12.1610.38","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.028860"},{"key":"2024101604050994000_50.12.1610.39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"key":"2024101604050994000_50.12.1610.40","first-page":"825","article-title":"Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis","volume":"30","author":"van Rossum","year":"2003","journal-title":"J Rheumatol"},{"key":"2024101604050994000_50.12.1610.41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.24495","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease","volume":"73","author":"Lantos","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2024101604050994000_50.12.1610.42","first-page":"379","article-title":"Lyme disease in Canada: focus on children","volume":"19","author":"Onyett","year":"2014","journal-title":"Paediatr Child Health"},{"key":"2024101604050994000_50.12.1610.43","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i10a01"},{"key":"2024101604050994000_50.12.1610.44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ584"},{"key":"2024101604050994000_50.12.1610.45","doi-asserted-by":"publisher","DOI":"10.1086\/322669"},{"key":"2024101604050994000_50.12.1610.46","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200201000-00003"},{"key":"2024101604050994000_50.12.1610.47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/acr.23870","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis","volume":"71","author":"Ringold","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2024101604050994000_50.12.1610.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.10.003"},{"key":"2024101604050994000_50.12.1610.49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.rbr.2015.08.010","article-title":"Intra-articular injection in patients with juvenile idiopathic arthritis: factors associated with a good response","volume":"56","author":"Cunha","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"2024101604050994000_50.12.1610.50","first-page":"291","article-title":"Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injection","volume":"32","author":"de Oliveira Sato","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2024101604050994000_50.12.1610.51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker165"},{"key":"2024101604050994000_50.12.1610.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.foot.2010.12.001"},{"key":"2024101604050994000_50.12.1610.53","doi-asserted-by":"crossref","first-page":"894S","DOI":"10.1177\/1947603520961173","article-title":"The assessment of steroid injections as a potential risk factor for osteochondral lesions in children with juvenile idiopathic arthritis","volume":"13","author":"Heidt","year":"2021","journal-title":"Cartilage"},{"key":"2024101604050994000_50.12.1610.54","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0088"},{"key":"2024101604050994000_50.12.1610.55","doi-asserted-by":"publisher","DOI":"10.1002\/art.23474"},{"key":"2024101604050994000_50.12.1610.56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semarthrit.2019.08.004","article-title":"Performance of the new \u201cEurofever\/PRINTO classification criteria\u201d in FMF patients","volume":"50","author":"Sag","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2024101604050994000_50.12.1610.57","doi-asserted-by":"publisher","DOI":"10.1093\/jlb\/lsx038"},{"key":"2024101604050994000_50.12.1610.58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00296-017-3688-3","article-title":"Physicians\u2019 perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome","volume":"37","author":"Manthiram","year":"2017","journal-title":"Rheumatol Int"},{"key":"2024101604050994000_50.12.1610.59","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/acr.22725","article-title":"Choosing Wisely in daily practice: an intervention study on antinuclear antibody testing by rheumatologists","volume":"68","author":"Lesuis","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2024101604050994000_50.12.1610.60","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2016.1190983"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2023-0043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:07:24Z","timestamp":1729076844000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2023-0043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,1]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.3899\/jrheum.2023-0043"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2023-0043","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"type":"print","value":"0315-162X"},{"type":"electronic","value":"1499-2752"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}